7AR-15259-31805
2 vaccinations
3 coded responses
22 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 190 / PA
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
- 2020-12-29
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2020-12-31
Survey response — days 1–6 daily, dose 1MedDRA: Cough — Feeling: Good · Site: PainFree text: CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-07
-
2021-01-19
Dose 2 — Pfizer-BioNTech
-
2021-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Headache, Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-02-09
- 2021-02-16
- 2021-02-24
- 2021-03-04
-
2021-04-22
Survey response — 3 months, dose 2MedDRA: Swelling face, Urticaria — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Face swelling/ hivesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-20
Survey response — 6 months, dose 2MedDRA: Angioedema, Urticaria — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Hives/ angioedemaMedDRA releases: 2024-11 · check-in free text available
-
2021-07-20
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-22
- 2022-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-22 | Unsuccessful | |
| 2021-07-20 | Unsuccessful |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Cough
Release 7 — 3 months, dose 2
Symptoms: Face swelling/ hives
Release 9 — 6 months, dose 2
Symptoms: Hives/ angioedema
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Angioedema | · | · | ✓ |
| SD | Swelling face | ✓ | ✓ | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release